USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name: TIGEN PHARMACEUTICALS
City: LEXINGTON
State: KY
Zip+4: 40506
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
Website URL: N/A
Phone: (606) 257-2300

Award Totals:

Program/Phase Award Amount ($) Number of Awards
STTR Phase I $333,125.00 4
STTR Phase II $284,000.00 1

Award List:

STABLE CAMPTOTHECIN FORMULATIONS FOR CANCER TREATMENT

Award Year / Program / Phase: 1998 / STTR / Phase I
Agency: HHS
Research Institution: Stehlin Foundation For Cancer Research
Principal Investigator: Burke
Award Amount: $100,000.00
RI Contact: N/A

Long Circulating Liposomal Camptothecins CAP and EAP

Award Year / Program / Phase: 2001 / STTR / Phase I
Agency: HHS
Research Institution: NEW YORK UNIVERSITY OF MEDICINE
Principal Investigator: Thomas G. Burke
Award Amount: $0.00
RI Contact: N/A
Abstract:
DESCRIPTION (provided by applicant): Based on the extensive data generated during the phase I portion of our studies, there is sufficient and compelling information to support the further development of the highly lipophilic and blood-stable topoisomerase inhibitor, DB-67.… More

Potent Topoisomerase I Inhibition For Glioma Therapy

Award Year / Program / Phase: 2001 / STTR / Phase I
Agency: HHS
Research Institution: UNIVERSITY OF KENTUCKY
Principal Investigator: Thomas G. Burke
Award Amount: $133,125.00
RI Contact: N/A
Abstract:
DESCRIPTION (PROVIDED BY APPLICANT): DB-67 is a promising new silatecan (silylcamptothecin) analog that displays superior blood stability relative to the FDA-approved camptothecin congeners, topotecan and CPT- 11. DB-67 also exhibits a high degree of anti-cancer potency… More